ARTHROPLASTY
Percutaneous neuromodulation pain therapy improves postoperative pain following TKR
J Knee Surg. 2011 Sep;24(3):197-20223 patients were randomized to evaluate the effectiveness of the Deepwave device, which utilizes percutaneous neuromodulation technology, in reducing pain and opioid use following total knee replacement (TKR). Patients received either the Deepwave treatment or sham treatment (set at 0% intensity) twice daily. The assessment revealed that the Deepwave device was effective in reducing the subjective measures of pain with a trend (but not significant) toward decreased use opioid use when compared to sham treatments.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
